Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Candarlioglu PL"'
Autor:
Tomlinson L; Global Pathology, Pfizer Inc., Cambridge, MA, 02140, USA., Ramsden D; DMPK Oncology, AstraZeneca, Boston, MA, 02451, USA., Leite SB; European Commission Joint Research Centre, Ispra, 21027, Italy., Beken S; Federal Agency for Medicines and Health Products, Brussels, 1210, Belgium., Bonzo JA; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA., Brown P; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA., Candarlioglu PL; Complex In Vitro Models, GSK, Stevenage, SG1 2NY, UK., Chan TS; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, 06877, USA., Chen E; DMPK, Genentech, South San Francisco, CA, 94080, USA., Choi CK; Preclinical Safety, Biogen, Cambridge, MA, 02142, USA., David R; Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge, CB2 0AA, UK., Delrue N; Organisation for Economic Co-operation and Development, Paris, 75016, France., Devine PJ; Discovery Toxicology, Bristol Myers Squibb, San Diego, CA, 09130, USA., Ford K; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA., Garcia MI; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Science, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA., Gosset JR; DMPK, Pfizer Inc., Cambridge, MA, 02139, USA., Hewitt P; Chemical and Preclinical Safety, Merck Healthcare KGaA, 64293, Darmstadt, Germany., Homan K; Complex in Vitro Systems Group, Genentech, South San Francisco, CA, 94080, USA., Irrechukwu O; Preclinical Sciences and Translational Safety, Johnson and Johnson Innovation Medicine, Spring House, PA, 19002, USA., Kopec AK; Drug Safety Research & Development, Pfizer Inc., Groton, CT, 06340, USA., Liras JL; Pharmacokinetics, Dynamics & Metabolism-Medicine Design, Pfizer, Cambridge, MA, 02139, USA., Mandlekar S; Clinical Pharmacology, Genentech, South San Francisco, CA, 94080, USA., Raczynski A; Preclinical Safety Assessment, Vertex Pharmaceuticals Inc., Boston, MA, 02210, USA., Sadrieh N; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA., Sakatis MZ; Non-Clinical Safety, In Vitro/In Vivo Translation, GSK R&D, Ware, SG12 9TJ, UK., Siegel J; Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA., Sung K; Center for Biologics Evaluation and Research, Office of Cellular Therapy and Human Tissue, Cellular and Tissue Therapy Branch, U.S. Food and Drug Administration, Silver Spring, MD, 20993, USA., Sunyovszki I; Translational Cellular Sciences, Biogen, Cambridge, MA, 02142, USA., Van Vleet TR; AbbVie, Inc., North Chicago, IL, 60064, USA., Ekert JE; UCB Pharma, Cambridge, MA, 02140, USA., Hardwick RN; Discovery Toxicology, Bristol Myers Squibb, San Diego, CA, 09130, USA.
Publikováno v:
Advanced biology [Adv Biol (Weinh)] 2024 Aug; Vol. 8 (8), pp. e2300131. Date of Electronic Publication: 2023 Oct 09.
Autor:
Candarlioglu PL; 3D and 3Rs Ltd., Cambridge, UK; previously at Complex In Vitro Models, GSK, Stevenage, UK., Delsing L; Cell & Gene Therapy Safety, Clinical Pharmacology & Safety Science, R&D, AstraZeneca, Mölndal, Sweden., Gauthier L; Drug Safety Research and Evaluation, Takeda Pharmaceuticals, Cambridge, MA, USA., Lewis L; Nonclinical Safety, Bristol Myers Squibb, Summit, NJ, USA., Papadopoulos G; Drug Safety Research and Evaluation, Takeda Pharmaceuticals, Cambridge, MA, USA., Freag M; Drug Safety Research and Evaluation, Takeda Pharmaceuticals, Cambridge, MA, USA., Chan TS; Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA., Homan KA; Complex in vitro Systems, Genentech Inc, South San Francisco, CA, USA., Fellows MD; Cell & Gene Therapy Safety, Clinical Pharmacology & Safety Science, R&D, AstraZeneca, Cambridge, UK., Pointon A; Cell & Gene Therapy Safety, Clinical Pharmacology & Safety Science, R&D, AstraZeneca, Cambridge, UK., Kojala K; Nonclinical Safety, Bristol Myers Squibb, Summit, NJ, USA.
Publikováno v:
ALTEX [ALTEX] 2024; Vol. 41 (3), pp. 469-484. Date of Electronic Publication: 2024 May 15.
Autor:
Candarlioglu PL; In Vitro/In Vivo Translation-Complex In Vitro Models, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K., Dal Negro G; In Vitro/In Vivo Translation-Complex In Vitro Models, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K., Hughes D; CN Bio Innovations Ltd, Cambridge, U.K., Balkwill F; Barts Cancer Institute, Queen Mary University of London, London, U.K., Harris K; National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, U.K., Screen H; School of Engineering and Material Science, Queen Mary University of London, London, U.K., Morgan H; Electronics and Computer Science, University of Southampton, Southampton, U.K., David R; Safety Innovation, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, U.K., Beken S; Federal Agency for Medicines and Health Products, Brussels, Belgium., Guenat O; ARTORG Center, University of Bern, Bern, Switzerland., Rowan W; Novel Human Genetics Research Unit GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K., Amour A; Immunology Research Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Publikováno v:
Biochemical Society transactions [Biochem Soc Trans] 2022 Apr 29; Vol. 50 (2), pp. 665-673.
Autor:
Clapp N; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K., Amour A; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K., Rowan WC; Novel Human Genetics Research Unit GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K., Candarlioglu PL; In vitro/In vivo Translation-Complex In Vitro Models, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Publikováno v:
Biochemical Society transactions [Biochem Soc Trans] 2021 Aug 27; Vol. 49 (4), pp. 1881-1890.